The addition of RvD2 to placental trophoblasts led to increased IL-10 expression indicating that RvD2 acts as a cellular anti-inflammatory nutrient compound similar to its effect observed in hypothalamus against acute inflammation during obesity [38]. Here, IL10 is linked to obesity due to melanocortin 4 receptor deficiency.